Total Payments
$3,061
2024 Payments
$357.27
Companies
14
Transactions
86
Medicare Patients
2,259
Medicare Billing
$184,132
Payment Breakdown by Category
Food & Beverage$2,893 (94.5%)
Education$168.05 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,893 | 80 | 94.5% |
| Education | $168.05 | 6 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $756.97 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $520.48 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $483.98 | 5 | $0 (2023) |
| Electromed, Inc. | $286.03 | 13 | $0 (2024) |
| Grifols USA, LLC | $215.65 | 3 | $0 (2024) |
| Insmed, Inc. | $212.89 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $173.03 | 4 | $0 (2023) |
| GENZYME CORPORATION | $166.20 | 5 | $0 (2024) |
| Genentech USA, Inc. | $99.99 | 1 | $0 (2019) |
| Tactile Systems Technology Inc | $49.35 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $357.27 | 16 | GENZYME CORPORATION ($166.20) |
| 2023 | $1,112 | 44 | GlaxoSmithKline, LLC. ($454.38) |
| 2022 | $670.41 | 11 | Electromed, Inc. ($168.13) |
| 2021 | $790.63 | 13 | Regeneron Healthcare Solutions, Inc. ($250.00) |
| 2019 | $130.08 | 2 | Genentech USA, Inc. ($99.99) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Immunology | ||||||
| 09/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Immunology | ||||||
| 08/02/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: HFCWO | ||||||
| 07/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Immunology | ||||||
| 07/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: Immunology | ||||||
| 05/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: Respiratory | ||||||
| 05/03/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.20 | General |
| Category: HFCWO | ||||||
| 04/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $8.24 | General |
| Category: HFCWO | ||||||
| 03/27/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $0.74 | General |
| Category: HFCWO | ||||||
| 02/27/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $12.55 | General |
| Category: HFCWO | ||||||
| 02/23/2024 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 01/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Pulmonology | ||||||
| 01/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.46 | General |
| Category: HFCWO | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Respiratory | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $3.77 | General |
| Category: RESPIRATORY | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,205 | 1,485 | $208,257 | $77,571 |
| 2022 | 12 | 970 | 1,325 | $200,797 | $90,511 |
| 2021 | 5 | 84 | 130 | $30,950 | $16,050 |
Total Patients
2,259
Total Services
2,940
Medicare Billing
$184,132
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 53 | 136 | $53,720 | $20,149 | 37.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 123 | 264 | $25,080 | $14,482 | 57.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 116 | 117 | $25,155 | $12,300 | 48.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 113 | $16,950 | $9,191 | 54.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 69 | 72 | $12,960 | $5,986 | 46.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 27 | $4,050 | $2,238 | 55.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 14 | 26 | $5,122 | $1,936 | 37.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 29 | 29 | $3,190 | $1,539 | 48.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 181 | 183 | $14,640 | $1,494 | 10.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 189 | 191 | $22,920 | $1,335 | 5.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $2,915 | $1,329 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $2,165 | $1,162 | 53.7% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 182 | 184 | $4,600 | $1,113 | 24.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 16 | 18 | $8,730 | $1,106 | 12.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 12 | 12 | $2,700 | $701.95 | 26.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 23 | 23 | $1,150 | $538.66 | 46.8% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 20 | 20 | $800.00 | $481.20 | 60.2% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 22 | 22 | $660.00 | $256.96 | 38.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 15 | 15 | $750.00 | $231.30 | 30.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 45 | 175 | $69,125 | $29,145 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 184 | $27,600 | $17,831 | 64.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 130 | 130 | $27,950 | $15,812 | 56.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 105 | 251 | $25,550 | $13,627 | 53.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 58 | 72 | $13,167 | $7,381 | 56.1% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 131 | 132 | $10,560 | $1,222 | 11.6% |
About Dr. Jatan Shah, MD
Dr. Jatan Shah, MD is a Critical Care Medicine healthcare provider based in Jamestown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2014. The National Provider Identifier (NPI) number assigned to this provider is 1871900720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jatan Shah, MD has received a total of $3,061 in payments from pharmaceutical and medical device companies, with $357.27 received in 2024. These payments were reported across 86 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,893).
As a Medicare-enrolled provider, Shah has provided services to 2,259 Medicare beneficiaries, totaling 2,940 services with total Medicare billing of $184,132. Data is available for 3 years (2021–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine
- Location Jamestown, NY
- Active Since 07/11/2014
- Last Updated 08/03/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1871900720
Products in Payments
- DUPIXENT (Biological) $650.18
- SMARTVEST (Device) $286.03
- TRELEGY ELLIPTA (Drug) $267.65
- FASENRA (Biological) $249.91
- BREZTRI (Drug) $226.96
- Prolastin-C Liquid (Biological) $215.65
- Arikayce (Drug) $212.89
- NUCALA (Biological) $190.86
- AREXVY (Drug) $173.48
- OFEV (Drug) $145.17
- Esbriet (Biological) $99.99
- Flexitouch Plus (Device) $49.35
- TEZSPIRE (Biological) $39.58
- STIOLTO RESPIMAT (Drug) $27.86
- GLASSIA (Biological) $26.12
- ARALAST (Biological) $22.95
- AIRSUPRA (Drug) $18.44
- Yupelri (Drug) $16.58
- INSPIRE (Device) $15.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.